Feb 4 (Reuters) - GE HealthCare on Wednesday forecast annual profit above Wall Street estimates, betting on robust demand for ...

Wednesday, GE HealthCare reported fourth-quarter earnings per share of $1.44 from sales of $5.7 billion. Wall Street was ...

GE HealthCare has achieved revenues of $20.6bn in fiscal year 2025 (FY25) amid ongoing imaging demand and now expects ...

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported Q4 CY2025 results exceeding the market’s ...

GE HealthCare posted full-year growth of 4.8% in 2025, including 7.1% revenue growth in its fourth quarter, beating analyst ...

GE HealthCare beat earnings and revenue estimates, saw strong growth in imaging and drug units, managed tariff costs and ...

GE HealthCare (Nasdaq: GEHC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast.

GE HealthCare (GEHC) stock gains as the company beats forecsts with its Q4 earnings and revenue and issues 2026 outlook also exceeding the consensus. Read more here.

The earnings results for GE HealthCare Techs (NASDAQ: GEHC) for Q4 were made public on Wednesday, February 4, 2026 at 06:20 ...

GEHC Q4 2025 earnings call recap: revenue, record backlog, 2026 guidance, Intelerad deal, Flyrcado ramp, tariffs & China risks—read key takeaways.

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.45 per share a year ago.